The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
Learn more about:
Related Clinical Trial
Identifying Maturity-onset Diabetes of the Young in Emirati Patients
Impact of SGLT2 on Glucosuria in HNF1A-MODY
Genetic Causes of Gestational Diabetes in the Emirati Population
Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes
MODY in Young-onset Diabetes in Different Ethnicities
The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)
Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)